Bio-Rad Laboratories (NYSE:BIO – Get Free Report) issued its quarterly earnings results on Thursday. The medical research company reported $3.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.55 by $0.45, Briefing.com reports. Bio-Rad Laboratories had a positive return on equity of 4.10% and a negative net margin of 7.01%. The […]
Bio-Rad Laboratories (NYSE:BIO – Get Free Report) posted its quarterly earnings results on Thursday. The medical research company reported $3.00 earnings per share for the quarter, topping analysts’ consensus estimates of $2.55 by $0.45, Briefing.com reports. Bio-Rad Laboratories had a negative net margin of 7.01% and a positive return on equity of 4.10%. The business […]
Bio-Rad Laboratories (NYSE:BIO – Get Free Report) announced its quarterly earnings data on Thursday. The medical research company reported $3.00 earnings per share for the quarter, beating analysts’ consensus estimates of $2.55 by $0.45, Briefing.com reports. The company had revenue of $681.10 million for the quarter, compared to analyst estimates of $697.96 million. Bio-Rad Laboratories […]
Bio-Rad Laboratories (NYSE:BIO – Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, August 3rd. Analysts expect Bio-Rad Laboratories to post earnings of $2.56 per share for the quarter. Bio-Rad Laboratories has set its FY 2023 guidance at EPS.Parties that wish to listen to the company’s […]
Daiwa Securities Group Inc. boosted its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 8.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,726 shares of the medical research company’s stock after buying an additional 132 shares during the […]